1                                              Parasitologic and nutritional assessments were carried o

2                                 Demographic, parasitologic, and ultrasound surveys were conducted on

3 DNA sequencing analysis) with those from the parasitologic approach (in vitro culture followed by iso

4                     (V.) braziliensis by the parasitologic approach; for the other patient, the resul

5                  Analyses of entomologic and parasitologic data collected in 1986-1987 were conducted

6 sistant P. falciparum did not exacerbate any parasitologic, histologic, or clinical measures of PAM m

7 enomegaly and hepatic fibrosis, but not with parasitologic measures, at 20 wk after infection.

8 ion), and was not associated with an adverse parasitologic outcome in any of the gene-targeted mouse

9 provided substantially improved clinical and parasitologic outcomes.

10 y day 7, and, through day 28, no clinical or parasitologic relapse had occurred in them.

11 r the primary outcome: adequate clinical and parasitologic response in the per-protocol population on

12 ain reaction-corrected adequate clinical and parasitologic response on day 28, parasite clearance tim

13 mether-lumefantrine, with rapid clinical and parasitologic response.

14 dence interval [CI], 0.47-0.93; P=.02) or in parasitologic treatment failure on day 7 (RR, 0.51; 95%